[동향보고] EU, CMR에 관한 REACH 규정 부속서 XVII 개정

최고관리자 0 6,752 2022.02.03 14:09

2021년 12월 14일, EU는 CMR 물질에 관한 REACH 규정 부속서 XVII 개정*을 공식 관보에 공표하였습니다.

* Commission Regulation (EU) 2021/2204 of 13 December 2021 amending Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), as regards carcinogenic, mutagenic or reproductive toxicant (CMR) substances

동 규정 부속서 XVII에 따라 발암성 〮돌연변이성 〮생식독성(CMR) 물질, 카테고리 1A 또는 1B로 분류되는 동 부속서 부록 1~6까지 등재된 물질 및 특정농도 이상의 해당 물질이 함유된 혼합물을 일반 대중에게 공급하기 위해 시장 출시 또는 사용을 금지합니다.

* Carcinogenic, Mutagenic or Reproductive toxicant

부속서 XVII의 주요 개정 내용은 다음과 같습니다.

○ ‘부록 2: 발암물질-카테고리 1B’ 목록에 다음의 물질 추가

물질명	Index No	EC No	CAS No
‘silicon carbide fibres (with diameter < 3 μm, length > 5 μm and aspect ratio ≥ 3:1)	014-048-00-5	206-991-8	409-21-2 308076-74-6’
‘dibenzo[def,p]chrysene;dibenzo[a,l]pyrene	601-092-00-0	205-886-4	191-30-0’
‘tetrafluoroethylene	602-110-00-X	204-126-9	116-14-3
‘1,4-dioxane	603-024-00-5	204-661-8	123-91-1’
‘m-bis(2,3-epoxypropoxy)benzene;resorcinol diglycidyl ether	603-065-00-9	202-987-5	101-90-6’
‘7-oxa-3-oxiranylbicyclo[4.1.0]heptane;1,2-epoxy-4-epoxyethylcyclohexane; 4-vinylcyclohexene diepoxide	603-066-00-4	203-437-7	106-87-6’
‘2,2-bis(bromomethyl)propane-1,3-diol	603-240-00-X	221-967-7	3296-90-0’
‘sodium N-(hydroxymethyl)glycinate;[formaldehyde released from sodium N-(hydroxymethyl)glycinate]	607-746-00-1	274-357-8	70161-44-3’
‘butanoneoxime; ethyl methyl ketoxime; ethyl methyl ketone oxime	616-014-00-0	202-496-6	96-29-7’
‘N-(hydroxymethyl)acrylamide;methylolacrylamide; [NMA]	616-230-00-5	213-103-2	924-42-5’

○ ‘부록 4: 생식세포 돌연변이물질-카테고리 1B’ 목록에 다음의 물질 추가

물질명	Index No	EC No	CAS No
‘2,2-bis(bromomethyl)propane-1,3-diol	603-240-00-X	221-967-7	3296-90-0’
‘N-(hydroxymethyl)acrylamide;methylolacrylamide; [NMA]	616-230-00-5	213-103-2	924-42-5’

○ ‘부록 6: 생식독성물질-카테고리 1B’ 목록에 다음의 물질 추가

물질명	Index No	EC No	CAS No
‘mancozeb(ISO); manganese ethylenebis (dithiocarbamate) (polymeric) complexwithzinc salt	006-076-00-1	-	8018-01-7’
‘tris(2-methoxyethoxy)vinylsilane;6-(2-methoxyethoxy)-6-vinyl-2,5,7,10-tetraoxa-6-silaundecane	014-050-00-6	213-934-0	1067-53-4’
‘dichlorodioctylstannane	050-021-00-4	222-583-2	3542-36-7’
‘dioctyltindilaurate; [1] stannane,dioctyl-, bis(coco acyloxy) derivs. [2]	050-031-00-9	222-883-3 [1] 293-901-5 [2]	3648-18-8[1] 91648-39-4[2]’
‘7-oxa-3-oxiranylbicyclo[4.1.0]heptane;1,2-epoxy-4-epoxyethylcyclohexane; 4-vinylcyclohexene diepoxide	603-066-00-4	203-437-7	106-87-6’
‘ipconazole(ISO); (1RS,2SR,5RS;1RS,2SR,5SR)-2-(4-chlorobenzyl)-5-isopropyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol	603-237-00-3	-	125225-28-7 115850-69-6 115937-89-8’
‘bis(2-(2-methoxyethoxy)ethyl)ether;tetraglyme	603-238-00-9	205-594-7	143-24-8’
‘6,6'-di-tert-butyl-2,2'-methylenedi-p-cresol;[DBMC]	604-095-00-5	204-327-1	119-47-1’
‘2-(4-tert-butylbenzyl)propionaldehyde	605-041-00-3	201-289-8	80-54-6’
‘diisooctylphthalate	607-740-00-9	248-523-5	27554-26-3’
‘2-methoxyethylacrylate	607-744-00-0	221-499-3	3121-61-7’
‘dimethomorph(ISO); (E,Z)-4-(3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholine	613-102-00-0	404-200-2	110488-70-5’
‘1,2,4-triazole	613-111-00-X	206-022-9	288-88-0’
‘pyrithionezinc; (T-4)-bis[1-(hydroxy-.kappa.O)pyridine-2(1H)-thionato-.kappa.S]zinc	613-333-00-7	236-671-3	13463-41-7’
‘flurochloridone(ISO);3-chloro-4-(chloromethyl)-1-[3-(trifluoromethyl)phenyl]pyrrolidin-2-one	613-334-00-2	262-661-3	61213-25-0’
‘3-methylpyrazole	613-339-00-X	215-925-7	1453-58-3’
‘bis(α,α-dimethylbenzyl)peroxide	617-006-00-X	201-279-3	80-43-3’